ID: ALA5200188

Max Phase: Preclinical

Molecular Formula: C15H11FN2O4S

Molecular Weight: 334.33

Representations

Canonical SMILES:  O=C(NCc1ccccc1F)N1C(=O)c2ccccc2S1(=O)=O

Standard InChI:  InChI=1S/C15H11FN2O4S/c16-12-7-3-1-5-10(12)9-17-15(20)18-14(19)11-6-2-4-8-13(11)23(18,21)22/h1-8H,9H2,(H,17,20)

Standard InChI Key:  PVAQEKOYPDHKAI-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 334.33

Molecular Weight (Monoisotopic): 334.0424

AlogP: 1.88

#Rotatable Bonds: 2

Polar Surface Area: 83.55

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 11.45

CX Basic pKa:

CX LogP: 2.19

CX LogD: 2.19

Aromatic Rings: 2

Heavy Atoms: 23

QED Weighted: 0.91

Np Likeness Score: -1.59

References

1. Wen W, Cao H, Xu Y, Ren Y, Rao L, Shao X, Chen H, Wu L, Liu J, Su C, Peng C, Huang Y, Wan J..  (2022)  N-Acylamino Saccharin as an Emerging Cysteine-Directed Covalent Warhead and Its Application in the Identification of Novel FBPase Inhibitors toward Glucose Reduction.,  65  (13.0): [PMID:35786925] [10.1021/acs.jmedchem.2c00336]

Source

Source(1):

• Scientific Literature